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Abstract
Background—Research on the association between antisocial personality disorder (ASPD) with 
comorbid mental disorders and sexually transmitted infection (STI)/HIV risk among inmates is 
scant despite the high prevalence of psychopathology and of STI/HIV in this population.
Methods—We used baseline data from Project DISRUPT, a cohort study conducted among 
incarcerated African American men (n= 207), to measure associations between ASPD and 
STI/HIV risk. We also conducted latent class analyses (LCAs) to identify subgroups defined by 
ASPD with comorbid stress, depression, and borderline personality disorder symptoms and 
measured associations between latent class membership and STI/HIV risk.
Results—Approximately 15% had ASPD and 39% reported depression. Controlling for 
sociodemographics, stress, and depression, ASPD was independently associated with illicit 
[AOR=3.23, 95% confidence interval (CI): 1.18–8.87] and injection drug use (AOR: 5.49, 95% CI: 
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1.23–24.42) but not with sexual risk. LCAs suggested that those at high risk of ASPD were likely 
to experience co-morbid mental disorders. ASPD comorbid with these disorders was linked to 
drug and sex risk.
Conclusions—STI/HIV prevention for inmates should incorporate diagnosis and treatment of 
ASPD and comorbid disorders, and interventions to address ASPD-related factors (e.g., 
impulsivity) that drive STI/HIV risk.
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Individuals involved in the criminal justice system, including those incarcerated in jail and 
prison or on probation/parole, experience disproportionate rates of sexually transmitted 
infections (STIs) and HIV (Centers for Disease Control and Prevention, 2011; Satterwhite, 
Joesoef, Datta, & Weinstock, 2008). The dual epidemics of criminal justice involvement and 
STI/HIV are concentrated among African Americans. As a result of racial bias in arrest, 
sentencing, and incarceration (Fellner, 2013), African American men are six times more 
likely to be incarcerated versus whites (Bureau of Justice Statistics, 2014). This population 
also experiences the highest rates of STI/HIV (Centers for Disease Control and Prevention, 
2014). There is a continued need to identify underlying factors that contribute to STI/HIV-
related behaviors and infection among African Americans involved in the criminal justice 
system (Khan, Epperson, & Comfort, 2012).
A substantial proportion of individuals involved in the criminal justice system have 
antisocial personality disorder (ASPD) (Fazel & Danesh, 2002), a risk factor for STI/HIV-
related drug use and sexual risk behaviors (e.g., noninjection and injection drug use, 
multiple/concurrent sexual partnerships, and sex trade involvement) (Brooner, Greenfield, 
Schmidt, & Bigelow, 1993; Kelley & Petry, 2000) and STI/HIV infection. ASPD is a 
persistent pattern of antisocial behaviors featuring disregard for and violation of the rights 
and feelings of others (Hare, Hart, & Harpur, 1991). The disorder is characterized by 
impulsivity and lack of concern for the consequences of one’s actions, which often leads to 
involvement in the criminal justice system and has direct implications for STI/HIV risk 
(Rosenblum, 2014). Those with ASPD are more likely to use injection drugs and engage in 
unsafe injection (Brooner, Bigelow, Strain, & Schmidt, 1990), use noninjection drugs, and, 
in turn, to engage in multiple sexual partnerships and sex trade (Compton, Cottler, 
Shillington, & Price, 1995; Gill, Nolimal, & Crowley, 1992) and to be infected with 
STI/HIV (Brooner et al., 1993; Erbelding, Hutton, Zenilman, Hunt, & Lyketsos, 2004). One 
prior study on ASPD and STI/HIV risk conducted in a sample of substance-abusing juvenile 
offenders indicated that those with high psychopathy reported more substance use and 
unprotected sex as well as less favorable attitudes toward condoms and intentions to engage 
in safer sex (Malow et al., 2007).
Despite high levels of ASPD among inmates, research on ASPD and STI/HIV-related risk in 
this population is scant and to our knowledge, no prior study has examined these 
associations among African American adults involved in the criminal justice system. We 
need improved understanding of the degree to which adult offenders with ASPD experience 
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heightened STI/HIV risk in order to target testing, treatment, and prevention programming. 
Evidence that ASPD is an independent correlate of STI/HIV risk among inmates would 
suggest STI/HIV prevention programming should incorporate methods specific to the 
antisocial tendencies and perceptions that underlie risk-taking.
While ASPD is an independent risk factor for STI/HIV risk, the disorder also frequently co-
occurs with other psychopathology that may work in concert with ASPD to exacerbate 
STI/HIV risk. ASPD is often dually diagnosed with borderline personality disorder (BPD) 
(Black et al., 2007; Black, Gunter, Loveless, Allen, & Sieleni, 2010). Like ASPD, BPD 
features impulsivity (Links, Heslegrave, & van Reekum, 1999; Swann, Lijffijt, Lane, 
Steinberg, & Moeller, 2009) and is linked to increased drug use (Hasin et al., 2011) and 
sexual risk (Harned, Pantalone, Ward-Ciesielski, Lynch, & Linehan, 2011; Hull, Clarkin, & 
Yeomans, 1993; Sansone, Lam, & Wiederman, 2011). Likewise, ASPD frequently co-occurs 
with depression, a risk factor for drug use, sexual risk behaviors and STI/HIV (Erbelding, 
Hummel, Hogan, & Zenilman, 2001; Khan et al., 2009; Stiffman, Dore, Earls, & 
Cunningham, 1992). ASPD is also associated with experiencing stressful life circumstances 
such as relationship difficulties and unemployment, and with decreased ability to engage in 
appropriate coping strategies in the face of stress (Bijttebier & Vertommen, 1999; Ireland, 
Brown, & Ballarini, 2006; National Collaborating Centre for Mental Health, 2010). Stress 
and poor coping are associated with STI/HIV risk (Mazzaferro et al., 2006; Sinha, 2001). 
Studies in high-risk populations have identified a syndemic effect of multiple mental 
disorders on substance use and sexual risk (Stall et al., 2003), yet no comparable study has 
been conducted among inmates. Research that identifies the degree to which ASPD may 
work not only independently but also together with other disorders or symptomatology to 
influence STI/HIV risk is needed to plan effective interventions.
The purpose of this study was to measure associations among ASPD, other mental disorder 
symptoms, and STI/HIV-related drug use and sexual risk among participants of Project 
DISRUPT (Dissolution of Intimate Stable Relationships Unique to the Prison Term), a 
cohort study conducted among African American men incarcerated in North Carolina who 
were in committed heterosexual partnerships at prison entry. Understanding the importance 
of mental disorders in the STI/HIV risk of inmates in committed partnerships is particularly 
important given those in committed partners are protected to some degree from STI/HIV 
risk, yet there is evidence that mental disorders may erode this protection from risk (Khan, 
Behrend, Adimora, Weir, Tisdale, et al., 2011; Khan, Behrend, Adimora, Weir, White, et al., 
2011). We aimed to describe associations between ASPD and STI/HIV-related risk 
behaviors.
In addition, we aimed to use latent class analysis (LCA) to explore the patterns of co-
occurrence of ASPD with stress and symptoms of two common disorders in this population
—depressive disorder and BPD (Black et al., 2007; Fazel & Danesh, 2002)—and evaluate 
the association between mental disorder latent class membership and STI/HIV risk. Because 
no prior studies have explored mental disorder class membership and STI/HIV risk among 
male inmates, we made no hypotheses regarding how specific groups would relate to 
substance use and sexual risk behaviors, though we did hypothesize that increased symptom 
severity would be associated with increased risk, as has been demonstrated in other 
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populations. Identifying the patterns of mental disorder symptoms and their severity could 
inform tailoring and customizing STI/HIV prevention programming to address the specific 
needs of inmates.
Methods
Study design and sample
We used baseline data from Project DISRUPT (N = 207) (Khan et al., 2015). Participants 
were recruited from the North Carolina Department of Public Safety (NCDPS) minimum 
and medium security prisons from September 2011 through January 2014. At baseline, 
participants completed audio-computer assisted self-interviewing (ACASI) survey and 
provided urine for STI testing. Study activities were approved by the Institutional Review 
Boards at requisite institutions including the NCDPS.
Approximately 1480 potential participants were screened for eligibility. Eligible participants 
were African American men at least 18 years old who were in a committed heterosexual 
partnership and HIV-negative at prison entry, had currently been incarcerated less than 3 
years, lived free in the community for ≥6 months before the current incarceration, and were 
soon to be released. To ensure study staff safety, inmates who were incarcerated for forcible 
rape, murder 1 or 2, and kidnapping were ineligible. Of those screened, 477 were eligible 
and 207 enrolled. Common reasons potential participants declined participation were a lack 
of time and not wanting to be followed after release. Due to data corruption, the current 
analysis includes 189 baseline surveys.
Measures
Antisocial personality disorder—We measured ASPD using a Structured Clinical 
Interview for DSM-IV Axis II (SCID-II) module-based instrument (First, Spitzer, Gibbon, & 
Williams, 1995), which assesses 22 indicators of ASPD in areas including disregard for 
other’s safety and remorselessness. Endorsement of ≥3 indicators from adolescence and ≥3 
indicators during adulthood is considered ASPD.
Stress and other mental disorder symptoms—Depression was measured with a 
modified five-item version of the 20-item Center for Epidemiologic Studies Depression 
(CES-D) scale (Perreira, Deeb-Sossa, Harris, & Bollen, 2005), on which participants rated 
how often they felt depressive symptoms in the six months before incarceration. Positive 
responses were reverse-coded and all responses were summed (range 0–15). The summed 
score was dichotomized at ≥4, the calibrated cut-point based on the original CES-D (range 
0–60, with scores ≥16 indicative of depression) (Lincoln, 2011). Participants rated stress felt 
living in the community on a 1–10 scale for seven topics: housing, food security, health, 
employment, violence, criminal justice involvement, and in general. Responses were 
summed to create a score (range 7–70). Participants reported the severity of problems caused 
by BPD symptoms such as mood swings or temper outbursts using a five-item modified 
version of the Borderline Evaluation of Severity over Time (BEST) (Blum, Pfohl, St. John, 
Monahan, & Black, 2002). Responses were summed (range 5–25). We used multiple 
imputations to impute summed BPD symptom severity and depression scores for 
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participants with incomplete responses (Rubin, 1987). Approximately 8% (n = 16) were 
incomplete for BPD symptom severity and 7% (n = 14) were incomplete for depression.
STI/HIV-related drug use and sexual risk—Unless otherwise indicated, drug use and 
sexual risk behaviors pertain to the 6 months before incarceration. Participants reported the 
number of standard drinks consumed on a typical day, which we dichotomized as ≥5 drinks 
versus ≤4 drinks to indicate binge drinking (National Institute on Alcohol Abuse and 
Alcoholism, n.d.). We defined lifetime illicit drug use as any prior use of cocaine, crack, 
ecstasy, and/or hallucinogens. Lifetime injection drug use was defined as any injection of 
drugs not prescribed by a doctor.
Multiple/concurrent sexual partnerships were defined as vaginal/anal sex with ≥2 partners 
and/or having vaginal/anal sex with one person during an overlapping time period the 
participant was having sex with someone else. We defined sex trade involvement as buying 
or selling sex for money, housing, or drugs. Prior STI was defined as report of ever being 
told they had a disease one can get from having sex, like gonorrhea or chlamydia.
Sociodemographics and lifetime criminal justice history—We examined 
sociodemographics and lifetime criminal justice history as potential covariates. Specifically, 
sociodemographics include age; joblessness, defined as lack of full or part-time 
employment; and food insecurity, defined as concern about having enough food to feed 
himself/family in the 6 months before incarceration. Lifetime criminal justice history 
indicators include the number of times previously incarcerated in jail or prison; number of 
years spent in prison, which was measured using categories of “<1 month,” “1–5 months,” 
“6–11 months,” “1–5 years,” or “> 5 years,” and collapsed into >5 years versus ≤5 years; 
and currently incarcerated for a violent crime based on NCDPS data.
Statistical analyses
We conducted univariate analyses to describe sociodemographics and criminal justice 
history, and bivariate analyses to calculate the prevalence of those indicators and STI/HIV-
related drug use and sexual risk by ASPD status. Logistic regression was used to calculate 
odds ratios (OR) and 95% confidence intervals (CI) for associations between ASPD, stress 
and other mental disorder symptoms, and STI/HIV-related outcomes. Multivariate models 
adjusted for age and joblessness, given joblessness was associated with ASPD and 
outcomes. Also, we estimated models that further adjusted for stress and depression to 
assess the independent associations between ASPD and outcomes. Analyses were conducted 
using SAS 9.3 (SAS Institute Inc. Cary, NC).
Because ASPD commonly co-occurs with other mental disorders symptoms, we sought to 
identify grouping of individuals based on mental disorder symptom severity and evaluate 
associations between group membership and STI/HIV risk outcomes. Using MPlus version 
7.1 (Muthén & Muthén, 1998–2007), we conducted LCAs to identify classes of mental-
disorder symptom severity based on ASPD, BPD symptom severity, depression, and stress. 
BPD symptom severity and stress scores were included as continuous indicators, while 
ASPD and depression were dichotomous. We estimated two, three, and four class solutions 
and considered model statistics as well as interpretability when selecting the optimal number 
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of the classes. We used multivariate logistic regression to examine the associations between 
latent class membership and STI/HIV risk outcomes.
Results
Participant sociodemographic characteristics and lifetime criminal justice history
Approximately 15% (n = 28) of participants met criteria for ASPD (Table 1). The mean age 
in the sample was 34.4 years. Odds of joblessness were over two times higher in those with 
ASPD (OR = 2.47, 95% CI: 1.09–5.60). Approximately 36% of participants with ASPD 
reported food insecurity compared to 21% without ASPD, though the association did not 
reach significance (p value = 0.08). Criminal justice history did not differ by ASPD status.
Associations between ASPD and STI/HIV-related drug use and sexual risk
ASPD was independently associated with specific STI/HIV-related drug use and sexual risk 
behaviors (Table 2). The disorder was strongly associated with lifetime illicit drug use, even 
after adjustment for sociodemographics, depression, and stress (AOR = 3.23, 95% CI: 1.18–
8.87). The odds of lifetime injection drug use were increased among those with ASPD (OR 
= 5.07, 95% CI: 1.27–20.21) and this association remained after adjustment for 
sociodemographics, depression, and stress (AOR = 5.49, 95% CI: 1.23–24.42). In analyses 
adjusted for sociodemographics, the odds of sex trade involvement (AOR = 3.25, 95% CI: 
1.05–10.10) and prior STI (AOR = 2.80, 95% CI: 1.20–6.51) were elevated among those 
with ASPD. Notably, these relationships lost significance in models further adjusting for 
other mental health symptoms.
Associations between ASPD and stress and other mental disorder symptoms
Those with ASPD experienced increased stress and other mental disorder symptoms, 
including almost three times the odds of depression (AOR = 2.82, 95% CI: 1.20–6.62; Table 
3).
Mental disorder symptom severity latent class membership
The three class solution was determined to best fit the data, based on both the fit statistics 
and interpretability (Table 4). The first latent class (n = 99; “low psychopathology”) was 
characterized by relatively low levels of all the mental health indicators (ASPD: 3%; 
depression 8.8%; estimated mean score for stress: 19.9; estimated mean score for BPD 
symptom severity: 6.7). The second class (n = 65; “general psychopathology”) was defined 
by moderate risk of ASPD (23.4%) and increased BPD symptom severity (estimated mean 
score 8.9), with high prevalence of depression (69.6%) and an estimated mean stress score of 
32.9. The third class (n = 25; “general psychopathology + BPD”) demonstrated similar 
levels of mental health factors as the second class, but was distinguished by approximately 
twice the estimate mean score for BPD symptom severity. Specifically, the prevalence of 
ASPD and depression in this class were 35.6% and 74%, respectively, the estimated mean 
stress score was 38.4, and the estimated mean score for BPD symptom severity was 18.5.
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Associations between mental disorder symptom severity latent class membership and STI/
HIV-related drug use and sexual risk
In analyses adjusted for age and joblessness, membership in the general psychopathology 
disorder class was not associated with drug use, but was associated with three times the odds 
of multiple/concurrent sexual partnerships (AOR = 3.14, 95% CI: 1.56–6.32) and 
approximately five times the odds of sex trade involvement (AOR = 4.78, 95% CI: 1.40–
16.20; Table 5).
Membership in the general psychopathology + BPD class was not associated with binge 
drinking or illicit drug use, but was associated with lifetime injection drug use (AOR = 6.18, 
95% CI: 1.23–30.97). General psychopathology + BPD class membership was strongly 
linked to sex risk behaviors, including multiple/concurrent partnerships (AOR = 2.90, 95% 
CI: 1.10–7.62), sex trade involvement (AOR = 7.09, 95% CI: 1.65–30.54), and prior STI 
(AOR = 3.66, 95% CI: 1.44–9.28).
Discussion
In this sample of African American men incarcerated in North Carolina who were in 
committed relationships at prison entry, 15% met criteria for ASPD. Those with ASPD 
experienced greater vulnerability to drug use, sexual risk behaviors, and prior STI and hence 
constitute a priority population for STI/HIV testing, treatment, and prevention. Results from 
this cross-sectional analysis suggest ASPD may be an independent driver of illicit and 
injection drug use, and comorbidity with other mental-disorder symptoms to drive sexual 
risk. Some associations between mental disorder symptom severity and STI/HIV risk were 
staggering; membership in the general psychopathology + BPD class was associated with 
seven times the odds of injection drug use and sex trade involvement. Results suggest ASPD 
in the context of other mental disorder symptoms should be addressed to improve well-being 
and reduce STI/HIV risk taking.
In extant literature from general and psychiatric samples, those with ASPD are more likely 
to experience comorbid BPD (Black et al., 2010; Zanarini et al., 1998), and personality 
disorders influence depression, stress, and anxiety (Farabaugh et al., 2005; Hirschfeld, 
1999). DISRUPT participants with ASPD also demonstrated increased depression, stress, 
and BPD symptoms, and we found membership in the latent class featuring the highest 
levels of mental health symptom severity conferred increased odds of STI/HIV-related drug 
use and sexual risk. Others have also documented that co-occurrence of mental disorders, as 
well as increasing symptom severity, are associated with elevated STI/HIV risk. For 
example, in a sample of inpatients with substance use disorder, increasing severity of 
posttraumatic stress disorder symptoms increased the risk of unprotected sex and sex trade 
(Weiss, Tull, Borne, & Gratz, 2013). In a New Zealand birth cohort, psychiatric comorbidity 
was associated with increased risk of unprotected sex with multiple partners (Ramrakha, 
Caspi, Dickson, Moffitt, & Paul, 2000). While one would hypothesize that increasing mental 
health symptom severity is linked to greater HIV risk behavior, no known studies have 
examined this among men involved in the criminal justice system despite the high 
prevalence of both mental disorders and STI/HIV-related substance use and sexual risk 
behavior in this population. Our findings indicate those with multiple mental disorders and 
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elevated symptom severity are a priority population for STI/HIV prevention intervention 
programming in the criminal justice system.
We found that the general psychopathology + BPD class demonstrated the greatest odds of 
sexual risk behavior, in addition to associations with illicit drug use. This class’s level of 
BPD symptom severity was twice as high as the general psychopathology class, yet levels of 
ASPD, depression, and stress were relatively similar. We are not able to determine if there is 
an interactive effect between ASPD and BPD on sexual risk in our sample, though it is 
possible the comorbidity of ASPD and high levels of BPD symptom severity may be 
uniquely associated with sexual risk behavior. Impulsivity is featured in both antisocial and 
BPDs, and co-occurring ASPD and BPD may exhibit profiles of impulsivity specific to each 
disorder that impact STI/HIV-related risk. Research suggests that the symptoms of mental 
disorders, including ASPD and BPD, are differentially related to impulsivity (Swann, 
Lijffijt, Lane, Steinberg, & Moeller, 2013) and that the mechanisms underlying impulsivity 
vary across disorders (Swann, Lijffijt, Lane, Steinberg, & Moeller, 2011). Beyond 
impulsivity alone, the combination of features of BPD, such as emotional dysregulation may 
result in elevated sexual risk-taking (Malow et al., 2007; Messman-Moore, Walsh, & 
DiLillo, 2010).
While US jails and prisons must provide mental health care for inmates, the screening and 
treatment methods are highly variable (U.S. Department of Justice, 2007) and mental illness 
often goes undetected (Teplin, 1990). The high prevalence of mental disorders among 
criminal justice populations indicates this is a missed opportunity. Treatment of comorbid 
mental disorders improves outcomes for those with ASPD (National Collaborating Centre 
for Mental Health, 2010). Our results suggest addressing antisocial behaviors with treatment 
of co-occurring mental disorder symptoms and skills building in coping with stress may be 
critical to reducing risk in a population that is highly vulnerable to STI/HIV. Personality 
disorders are difficult to treat but interventions for personality disorders such as BPD are 
effective (Linehan, 1987; Linehan et al., 2006) and may have implications for addressing the 
STI/HIV risk of those with ASPD given the overlap in symptoms between the two disorders. 
In addition, members of our group have developed and evaluated interventions designed to 
reduce distress intolerance and impulsivity, key features of ASPD and BPD that are linked to 
drug and sex risk and these intervention approaches have been effective in populations with 
high prevalence of both ASPD and BPD (Bornovalova, Gratz, Daughters, Hunt, & Lejuez, 
2012). Finally, even though all participants had a committed partner at prison entry, those 
with ASPD may not consider ways in which their own actions may impact the health and 
wellbeing of their partner (Gutman, McDermut, Miller, Chelminski, & Zimmerman, 2006). 
Interventions that address the mental health factors driving STI/HIV-related risk behaviors of 
the inmate could also be beneficial to the STI/HIV risk of their committed partner.
The prevalence of ASPD in our sample was 15%, the lower range reported within other 
incarcerated samples (Black, Arndt, Hale, & Rogerson, 2004; Black et al., 2010; Blackburn 
& Coid, 1999; Fazel & Danesh, 2002), though much higher than levels of 0.5–5.8% in the 
general population (Compton, Conway, Stinson, Colliver, & Grant, 2005; Grant et al., 2004). 
Our sample’s prevalence is partly a result of Project DISRUPT’s eligibility criteria. Each 
participant had to have a committed partner at prison entry to be eligible for study inclusion, 
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and antisocial tendencies inhibit ability to form personal commitments. Yet the strong 
associations demonstrated in our sample indicate the results likely apply to other 
incarcerated populations and the population-level impact of ASPD on STI/HIV risk may be 
considerable, as up to half of inmates have the disorder (Fazel & Danesh, 2002).
This study faces a number of limitations. First, findings may not be generalizable to other 
incarcerated samples given our relatively restrictive eligibility criteria. Residual confounding 
from unmeasured factors is possible. The cross-sectional study design is a further limitation, 
such that we could not determine the temporal ordering of confounding factors (e.g., 
joblessness), ASPD, and STI/HIV risk. The small sample size and low prevalence of ASPD 
made it difficult to detect independent associations between the disorder and outcomes. 
Assessment of mental health was based on self-reported measures not intended for 
diagnoses and therefore represents symptom severity rather than disorder status. Finally, 
recall and social desirability bias could influence estimates. Our mental health measures 
concerned the time frame six months prior to incarceration, though recollection could have 
been influenced by current circumstances and there may be underreporting of risk behaviors 
due to their sensitive nature.
Conclusions
In conclusion, this is the first study to our knowledge to assess associations among ASPD, 
stress and other mental-disorder symptoms, and STI/HIV-related drug use and sexual risk in 
incarcerated adult males. Results indicate that African American inmates in committed 
partnerships diagnosed with ASPD are particularly vulnerable to STI/HIV-related drug use 
and sexual risk. The results suggest that ASPD is an independent risk factor for illicit and 
injection drug use and that comorbidity with other disorders may drive sexual risk. STI/HIV 
prevention among inmates would benefit from increased diagnosis of ASPD, treatment of 
comorbid disorders, and interventions to address antisocial tendencies underlying risk taking 
and infection.
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Table 2
Odds ratios (ORs) and 95% confidence intervals (CI) for associations between ASPD and STI/HIV-related 
substance use and sexual risk among incarcerated African American men in committed partnerships (Project 
DISRUPT; N = 189).





≥5 drinks on typical day in the six 
months before incarceration
 Non-ASPD 23.8 1.00 1.00 1.00
 ASPD 17.4 0.68 (0.22, 2.12) 0.57 (0.18, 1.86) 0.51 (0.15, 1.70)
Lifetime illicit drug use
 Non-ASPD 52.2 1.00 1.00 1.00
 ASPD 78.6 3.35 (1.29, 8.72) 3.72 (1.39, 9.96) 3.23 (1.18, 8.87)
Lifetime injection drug use
 Non-ASPD 3.2 1.00 1.00 1.00
 ASPD 14.3 5.07 (1.27, 20.21) 6.01 (1.41, 25.64) 5.49 (1.23, 24.42)
Multiple/concurrent sexual partnerships
 Non-ASPD 46.1 1.00 1.00 1.00
 ASPD 47.1 1.56 (0.69, 3.52) 1.44 (0.62, 3.67) 1.05 (0.43, 2.58)
Sex trade involvement
 Non-ASPD 8.9 1.00 1.00 1.00
 ASPD 21.4 2.81 (0.98, 8.07) 3.25 (1.05, 10.10) 1.49 (0.42, 5.27)
Prior STI
 Non-ASPD 31.9 1.00 1.00 1.00
 ASPD 55.6 2.67 (1.17, 6.13) 2.80 (1.20, 6.51) 2.25 (0.93, 5.54)
a
Adjusted for age and joblessness.
b
Adjusted for age, joblessness, stress score, and depression.
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Table 3
ORs and 95% CI for associations between ASPD, stress and other mental disorder symptoms among 
incarcerated African American men in committed partnerships (Project DISRUPT; N = 189).
% with outcome Mean (SD) Unadjusted OR (95% CI) Adjusteda OR (95% CI)
Depression (score≥4)
 Non-ASPD 34.8 1.00 1.00
 ASPD 64.3 3.38 (1.46, 7.80) 2.82 (1.20, 6.62)
Stress level while in community
 Non-ASPD 25.6 (12.6) 1.00 1.00
 ASPD 34.8 (15.5) 1.05 (1.02, 1.08) 1.05 (1.01, 1.08)
BPD symptom severity score
 Non-ASPD 8.5 (4.1) 1.00 1.00
 ASPD 12.0 (5.7) 1.15 (1.06, 1.24) 1.13 (1.04, 1.22)
a
Adjusted for age and joblessness.
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Table 5
Associations between mental disorder symptom severity latent class and STI/HIV-related substance use and 
sexual risk in the six months before incarceration among incarcerated African American men in committed 
partnerships (Project DISRUPT; N = 189).
% with outcome OR (95% CI) AORa (95% CI)
≥5 drinks on typical day in the six months before incarceration
 Low psychopathology (n= 99) 19.3 1.00 1.00
 General psychopathology (n= 65) 23.8 1.31 (0.60, 2.86) 1.39 (0.62, 3.10)
 General psychopathology+ BPD (n = 25) 27.3 1.57 (0.53, 4.60) 1.65 (0.55, 4.97)
Lifetime illicit drug use
 Low psychopathology (n= 99) 51.6 1.00 1.00
 General psychopathology (n= 65) 58.5 1.32 (0.70, 2.50) 1.33 (0.69, 2.57)
 General psychopathology + BPD (n = 25) 68.0 2.00 (0.79, 5.06) 2.12 (0.81, 5.51)
Lifetime injection drug use
 Low psychopathology (n= 99) 3.2 1.00 1.00
 General psychopathology (n= 65) 3.1 0.97 (0.16, 6.00) 0.94 (0.15, 5.81)
 General psychopathology + BPD (n = 25) 16.0 5.84 (1.22, 28.08) 6.18 (1.23, 30.97)
Multiple/concurrent sexual partnerships
 Low psychopathology (n= 99) 34.8 1.00 1.00
 General psychopathology (n= 65) 60.9 2.93 (1.51, 5.66) 3.14 (1.56, 6.32)
 General psychopathology + BPD (n = 25) 62.5 3.13 (1.23, 7.93) 2.90 (1.10, 7.62)
Sex trade involvement
 Low psychopathology (n= 99) 4.2 1.00 1.00
 General psychopathology (n= 65) 16.9 4.63 (1.41, 15.28) 4.78 (1.40, 16.20)
 General psychopathology + BPD (n = 25) 20.00 5.69 (1.40, 23.09) 7.09 (1.65, 30.54)
Prior STI
 Low psychopathology (n= 99) 28.7 1.00 1.00
 General psychopathology (n= 65) 36.9 1.45 (0.74, 2.85) 1.62 (0.81, 3.23)
 General psychopathology + BPD (n = 25) 56.0 3.16 (1.27, 7.82) 3.66 (1.44, 9.28)
a
Adjusted for age and joblessness.
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